Divestments

Clinical Innovations

Clinical Innovations is the leading, global pure-play provider of single-use clinician-preferred medical devices for hospitals’ Labor & Delivery (L&D) and Neonatal Intensive Care Unit (NICU) departments.

Founded in 1993, Clinical Innovations is the largest independent medical device company exclusively focused on L&D.

  • Sector
    Healthcare
  • Country
    United States
  • Fund
    EQT Mid Market US,EQT Mid Market Asia III
  • Entry
    2017
  • Exit
    2020-02-01

Already a market leader in several categories with products such as the Kiwi® Vacuum-Assisted Delivery System and Koala® Intrauterine Pressure Catheter, Clinical Innovations is developing state-of-the-art technologies and innovative medical devices that fulfill its mission of improving the lives of mothers and babies around the world. The Company has a well-balanced L&D and NICU portfolio of best-in-class, market-leading, established products as well as high-growth new products.

Clinical Innovations has built the industry’s largest specialized L&D-focused sales force and has developed strong relationships with specialty medical device distributors around the world.

In February, 2020, EQT sold Clinical Innovations to LABORIE Medical Technologies.

Subscribe for the latest updates

Subscribe to EQT's press releases, regulatory press releases and updates.

Type of news
Preferred language
EQT logo
A purpose-driven global investment organization
© EQT AB 2021. EQT AB (PUBL). REGISTRATED OFFICE IN STOCKHOLM, SWEDEN. REGISTRATION NUMBER: 556849-4180